Molecular, serological, and virulence characteristics of Vibrio parahaemolyticus isolated from environmental, food, and clinical sources in North America and Asia.
Potential virulence attributes, serotypes, and ribotypes were determined for 178 pathogenic Vibrio parahaemolyticus isolates from clinical, environmental, and food sources on the Pacific, Atlantic, and Gulf Coasts of the United States and from clinical sources in Asia. The food and environmental isolates were generally from oysters, and they were defined as being pathogenic by using DNA probes to detect the presence of the thermostable direct hemolysin (tdh) gene. The clinical isolates from the United States were generally associated with oyster consumption, and most were obtained from outbreaks in Washington, Texas, and New York. Multiplex PCR was used to confirm the species identification and the presence of tdh and to test for the tdh-related hemolysin trh. Most of the environmental, food, and clinical isolates from the United States were positive for tdh, trh, and urease production. Outbreak-associated isolates from Texas, New York, and Asia were predominantly serotype O3:K6 and possessed only tdh. A total of 27 serotypes and 28 ribogroups were identified among the isolates, but the patterns of strain distribution differed between the serotypes and ribogroups. All but one of the O3:K6 isolates from Texas were in a different ribogroup from the O3:K6 isolates from New York or Asia. The O3:K6 serotype was not detected in any of the environmental and food isolates from the United States, and none of the food or environmental isolates belonged to any of the three ribogroups that contained all of the O3:K6 and related clinical isolates. The combination of serotyping and ribotyping showed that the Pacific Coast V. parahaemolyticus population appeared to be distinct from that of either the Atlantic Coast or Gulf Coast. The fact that certain serotypes and ribotypes contained both clinical and environmental isolates while many others contained only environmental isolates implies that certain serotypes or ribotypes are more relevant for human disease.
DePaola
Angelo
A
Gulf Coast Seafood Laboratory, U.S. Food and Drug Administration, Dauphin Island, AL 36528, USA. adepaola@cfsan.fda.gov
Ulaszek
Jodie
J
Kaysner
Charles A
CA
Tenge
Bradley J
BJ
Nordstrom
Jessica L
JL
Wells
Joy
J
Puhr
Nancy
N
Gendel
Steven M
SM
D000818:Animals; D001208:Asia / Q000453:epidemiology; D001427:Bacterial Toxins; D004783:Environmental Microbiology; D005516:Food Microbiology; D006460:Hemolysin Proteins / Q000235:genetics / Q000378:metabolism; D006801:Humans; D010125:Ostreidae / Q000821:virology*; D016133:Polymerase Chain Reaction; D021521:Ribotyping; D012703:Serotyping; D014481:United States / Q000453:epidemiology; D014735:Vibrio Infections / Q000453:epidemiology / Q000382:microbiology*; D014736:Vibrio parahaemolyticus / Q000145:classification* / Q000235:genetics / Q000472:pathogenicity*; D014774:Virulence
D001427:Bacterial Toxins; D006460:Hemolysin Proteins; C068489:thermostable direct hemolysin